D Brent Polk

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Irritable Bowel Syndrome

Infectious Diseases

Top Venues

Advances in therapy

American journal of physiology. Gastrointestinal and liver physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Nandini Girish, Cambrian Y Liu, Safina Gadeock, Marie L Gomez, Ying Huang, Zohreh Sharifkhodaei, M Kay Washington, D Brent Polk
Persistence of Lgr5+ colonic epithelial stem cells in mouse models of inflammatory bowel disease. American journal of physiology. Gastrointestinal and liver physiology 321 (3) (2021)